Amid ongoing concern over clinical trial transparency, a new analysis finds that only 37% of the 14 largest public and philanthropic organizations that fund clinical research in the U.S. have implemented the best disclosure practices recommended by the World Health Organization.
On a bright note, all 14 organizations required open access publishing, which refers to freely available, online distribution. But on other measures, many organizations fell short – only nine required trials to be registered with ClinicalTrials.gov, a federal government database, in advance. Just six required results to be posted to the site within 12 months after a study was completed.
Moreover, only five organizations required research findings to be published in journals. Still worse, just two organizations required an assigned ID number to appear in all publications, which can make it easier to search online. Similarly, only two organizations made public any reports showing trials were registered and results were later reported as required.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
